Hirth Peter 4
4 · Aligos Therapeutics, Inc. · Filed Jun 17, 2021
Insider Transaction Report
Form 4
Hirth Peter
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-17+15,000→ 15,000 totalExercise: $26.58Exp: 2031-06-17→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual meeting in 2022 of the Issuer's stockholders, assuming continuous service as a director until such vesting date.